FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2320248812> ?p ?o ?g. }

• W2320248812 endingPage "26" @default.
• W2320248812 startingPage "20" @default.
• W2320248812 abstract "Near 75% of all breast cancers (BC) express estrogen receptors (ER) and/or progesterone receptors (PgR), while up to 20% of BC show an overexpression/amplification of Human Epidermal Growth Factor Receptor 2 (HER2). Around 50% of all HER2-overexpressing BC show the coexistence of both HER2 overexpression/amplification and ER and/or PgR overexpression. Numerous in vitro and in vivo studies suggest the existence of a cross-talk between their downstream pathways, which seem to affect the natural history, response to therapy and outcome of patients affected by this subset of BC. Meta-analyses or subgroup analysis of numerous neo-/adjuvant trials demonstrated significant clinical implications deriving from ER/HER2 co-existence, consisting in a different pattern of relapse and dissimilar outcome in response to anti-HER2 therapy. However, only two randomized trials in early disease and three in advanced disease specifically addressed the issue whether a combined approach with both hormonal and anti-HER2 therapy would have a better therapeutic impact in this subset of BC compared to the lone anti-HER2 or hormonal therapies (HT). None of these trials demonstrated improvements in overall survival, even though several efficacy end-points such as progression free survival, in advanced setting, or pCR rates in neoadjuvant setting, often favored the combined hormonal and anti-HER2 therapeutic approach. In the next few years, a certain number of ongoing randomized trials, both in neoadjuvant and advanced setting, will evaluate the efficacy of new anti-HER2 drugs, T-DM1 and pertuzumab, in combination with HT, helping to improve the therapeutic strategy for this specific subtype of breast tumors." @default.
• W2320248812 created "2016-06-24" @default.
• W2320248812 creator A5006857854 @default.
• W2320248812 creator A5008991955 @default.
• W2320248812 creator A5034879633 @default.
• W2320248812 creator A5054019294 @default.
• W2320248812 creator A5074479074 @default.
• W2320248812 creator A5078562748 @default.
• W2320248812 date "2016-05-01" @default.
• W2320248812 modified "2023-09-25" @default.
• W2320248812 title "Hormone Receptor/Human Epidermal Growth Factor Receptor 2-positive breast cancer: Where we are now and where we are going" @default.
• W2320248812 cites W1595886999 @default.
• W2320248812 cites W1641388025 @default.
• W2320248812 cites W1820219315 @default.
• W2320248812 cites W1820767183 @default.
• W2320248812 cites W1873831426 @default.
• W2320248812 cites W1898692666 @default.
• W2320248812 cites W1995859582 @default.
• W2320248812 cites W1997381761 @default.
• W2320248812 cites W2021723847 @default.
• W2320248812 cites W2037769103 @default.
• W2320248812 cites W2040142253 @default.
• W2320248812 cites W2056579307 @default.
• W2320248812 cites W2064823103 @default.
• W2320248812 cites W2075894019 @default.
• W2320248812 cites W2078140185 @default.
• W2320248812 cites W2086224272 @default.
• W2320248812 cites W2088573877 @default.
• W2320248812 cites W2089071484 @default.
• W2320248812 cites W2089589284 @default.
• W2320248812 cites W2091864171 @default.
• W2320248812 cites W2096884232 @default.
• W2320248812 cites W2105882193 @default.
• W2320248812 cites W2108863890 @default.
• W2320248812 cites W2111578514 @default.
• W2320248812 cites W2117357260 @default.
• W2320248812 cites W2120676861 @default.
• W2320248812 cites W2127362596 @default.
• W2320248812 cites W2129110050 @default.
• W2320248812 cites W2137228442 @default.
• W2320248812 cites W2140055441 @default.
• W2320248812 cites W2141393790 @default.
• W2320248812 cites W2143937001 @default.
• W2320248812 cites W2145257123 @default.
• W2320248812 cites W2146308386 @default.
• W2320248812 cites W2146378328 @default.
• W2320248812 cites W2146383973 @default.
• W2320248812 cites W2147415463 @default.
• W2320248812 cites W2148320836 @default.
• W2320248812 cites W2150086065 @default.
• W2320248812 cites W2155560234 @default.
• W2320248812 cites W2159938731 @default.
• W2320248812 cites W2159967578 @default.
• W2320248812 cites W2165432902 @default.
• W2320248812 cites W2292154624 @default.
• W2320248812 cites W2408313053 @default.
• W2320248812 cites W2602729445 @default.
• W2320248812 doi "https://doi.org/10.1016/j.ctrv.2016.03.012" @default.
• W2320248812 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27057657" @default.
• W2320248812 hasPublicationYear "2016" @default.
• W2320248812 type Work @default.
• W2320248812 sameAs 2320248812 @default.
• W2320248812 citedByCount "77" @default.
• W2320248812 countsByYear W23202488122016 @default.
• W2320248812 countsByYear W23202488122017 @default.
• W2320248812 countsByYear W23202488122018 @default.
• W2320248812 countsByYear W23202488122019 @default.
• W2320248812 countsByYear W23202488122020 @default.
• W2320248812 countsByYear W23202488122021 @default.
• W2320248812 countsByYear W23202488122022 @default.
• W2320248812 countsByYear W23202488122023 @default.
• W2320248812 crossrefType "journal-article" @default.
• W2320248812 hasAuthorship W2320248812A5006857854 @default.
• W2320248812 hasAuthorship W2320248812A5008991955 @default.
• W2320248812 hasAuthorship W2320248812A5034879633 @default.
• W2320248812 hasAuthorship W2320248812A5054019294 @default.
• W2320248812 hasAuthorship W2320248812A5074479074 @default.
• W2320248812 hasAuthorship W2320248812A5078562748 @default.
• W2320248812 hasBestOaLocation W23202488121 @default.
• W2320248812 hasConcept C121608353 @default.
• W2320248812 hasConcept C126322002 @default.
• W2320248812 hasConcept C143998085 @default.
• W2320248812 hasConcept C23589133 @default.
• W2320248812 hasConcept C2777176818 @default.
• W2320248812 hasConcept C2777863537 @default.
• W2320248812 hasConcept C2778292576 @default.
• W2320248812 hasConcept C2778311097 @default.
• W2320248812 hasConcept C2779786085 @default.
• W2320248812 hasConcept C2781164504 @default.
• W2320248812 hasConcept C502942594 @default.
• W2320248812 hasConcept C530470458 @default.
• W2320248812 hasConcept C535046627 @default.
• W2320248812 hasConcept C71924100 @default.
• W2320248812 hasConcept C84606932 @default.
• W2320248812 hasConceptScore W2320248812C121608353 @default.
• W2320248812 hasConceptScore W2320248812C126322002 @default.
• W2320248812 hasConceptScore W2320248812C143998085 @default.
• W2320248812 hasConceptScore W2320248812C23589133 @default.

• next